SCHEMBL7705079

SCHEMBL7705079

C[n+]1ccc([C]=O)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14596519 0.77 HDAC8 (0.62)
SCHEMBL5455838 0.72
SCHEMBL17107908 0.72
SCHEMBL195027 0.72
SCHEMBL104811 0.71 APP (0.32)
SCHEMBL7702350 0.70
Iodide SCHEMBL7051892 0.70 HDAC8 (0.95)
Hydrochloric Acid SCHEMBL5831783 0.70 HDAC8 (0.95)
SCHEMBL18870374 0.70 HDAC8 (0.54)
SCHEMBL4067660 0.69 APP (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1226167-A1 MODIFIED PEPTIDES AND PEPTIDOMIMETICS FOR USE IN IMMUNOTHERAPY Akzo Nobel N.V. (NL) 2002-07-31 EP claimed
WO-2001029081-A1 MODIFIED PEPTIDES AND PEPTIDOMIMETICS FOR USE IN IMMUNOTHERAPY AKZO NOBEL N.V. (NL) 2001-04-26 WO claimed
EP-1226167-A1 MODIFIED PEPTIDES AND PEPTIDOMIMETICS FOR USE IN IMMUNOTHERAPY Akzo Nobel N.V. (NL) 2002-07-31 EP disclosed
WO-2001029081-A1 MODIFIED PEPTIDES AND PEPTIDOMIMETICS FOR USE IN IMMUNOTHERAPY AKZO NOBEL N.V. (NL) 2001-04-26 WO disclosed